The patent covers the company’s vital signs monitoring system that it’s developing.

Katie Hobbins, Managing Editor

February 1, 2023

1 Min Read
patented (Nuthawut Somsuk_iStock) (1).jpg
Nuthawut Somsuk / iStock via Getty Images

G Medical Innovations Holdings, a healthcare company developing next generation mHealth and telemedicine solutions and monitoring service platforms, is adding a new patent to its portfolio with its announcement of a patent issue notification from the United States Patent and Trademark Office (USPTO).

The patent, which is expected to be issued on Feb. 7, 2023, under USPTO’s Method and System for Vital Signs Monitoring with Earpiece section, covers the vital signs monitoring system the company is developing using multiple sensing mechanisms to be used on different body locations. The monitoring system, according to G Medical, could potentially provide physicians more versatility in patient monitoring, simplifying in- and out-patient monitoring.  

The company’s product line consists of its Prizma medical device — a clinical-grade device that can transform almost any smartphone into a medical monitoring device; and its Extended Holter and Monitoring Cardiac Telemetry Patch services — multi-channel patient-worn biosensors, enabling real-time analysis and transmission that captures electrocardiography data continuously, including QT Syndrome Prolongation Detection. In development is the Wireless Vital Signs Monitoring System, which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. As part of its monitoring service, it includes provision of Independent Diagnostic Testing Facility monitoring services and private monitoring services.

Over the company’s product portfolio, it has been granted six patents — four in the US and two in China. Two of the patents were received only last month, in December 2022. Currently, G Medical has three more patents pending approval from the USPTO.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like